BMP2 and lung adenocarcinoma: To test whether BMP2 promotes lung adenocarcinoma mobility through the epithelial-to-mesenchymal transition (EMT), we depleted the expression of BMP2 using lentiviral-mediated shRNA delivery to CL1-5 and AS2 cells.